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Abstract
DNA damage accumulates in genome DNA during the long life of neurons, thus DNA damage repair is indispensable to
keep normal functions of neurons. We previously reported that Ku70, a critical molecule for DNA double strand break (DSB)
repair, is involved in the pathology of Huntington’s disease (HD). Mutant huntingtin (Htt) impaired Ku70 function via direct
interaction, and Ku70 supplementation recovered phenotypes of a mouse HD model. In this study, we generate multiple
Drosophila HD models that express mutant huntingtin (Htt) in eye or motor neuron by different drivers and show various
phenotypes. In such fly models, Ku70 co-expression recovers lifespan, locomotive activity and eye degeneration. In contrast,
Ku70 reduction by heterozygous null mutation or siRNA-mediated knock down accelerates lifespan shortening and
locomotion disability. These results collectively support that Ku70 is a critical mediator of the HD pathology and a candidate
therapeutic target in HD.
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Introduction
DNA damage repair was recently shown to be a critical
component of the polyQ disease pathology, in addition to
previously known pathologies including transcription [1–4],
splicing [5], protein degradation [6–8], autophagy [9–11], synapse
transmission [12–14], endocytosis [15,16], mitochondrial mem-
brane stability [17,18], energy metabolism [19–21] and oxidative
stress response [22–24].
The first implication of DNA damage repair in the HD
pathology came from the age-dependent CAG repeat expansion of
the HD gene. Oxoguanine glycosylase 1 (OGG1), a critical enzyme
for single base excision repair, enhances the age-dependent CAG
repeat instability [25], suggesting that genome DNA including the
HD gene faces continuous DNA damage during life. Another line
of evidence for DNA damage repair in HD came from our
previous results that mutant Htt impairs HMGB1/2 (high mobility
group box 1/2) and Ku70 proteins [26,27] indispensable for DSB
repair [28].
In DNA damage repair, unwinding genomic DNA from histone
complex is a crucial process. HMGB1/2 proteins possessing
positive- and negative-charge domains play this role through
insertion between genomic DNA and histone complex [29]. On
the other hand, Ku70/Ku80 heterodimer firstly detects DSBs and
assembles at the foci. The heterodimer recruits DNA-PKcs and
initiates the non-homologous end joining (NHEJ) type of DSB
repair by XRCC4/DNA ligase IV [30]. Therefore, functional
impairment of HMGB1/2 or Ku70 by mutant Htt finally
increases DSBs and triggers DNA damage signals [26,27].
In this study, we employ Drosophila genetics to reconfirm
involvement of Ku70 in HD pathology and therapeutic
application of Ku70 for the fly model. Ku70 overexpression
remarkably recovers lifespan, locomotion and eye thickness
phenotypes in newly generated multiple Drosophila HD models.
Non-sense mutation or RNAi-mediated suppression of Drosoph-
ila Ku70 (DmKu70) accelerates mutant Htt-induced phenotypes.
These results support involvement of Ku70 in the HD pathology,
and strongly suggest availability of Ku70 as a novel therapeutic
target.
Results
Ku70 rescues mutant Htt-induced eye degeneration in
Drosophila
Drosophila has a conserved DSB repair system including Ku70
(DmKu70/IRBP/YPF1/mus309/CG5247), Ku80 (DmKu80/
CG18801) and an unidentified DNA-PKcs [31,32] (http://
flybase.bio.indiana.edu). DmKu70’s function in DSB is known to
be evolutionary conserved [33]. Therefore, we tested the effect of
Ku70 on neurodegeneration in Drosophila. Expression of mutant
human Htt120Q exon1 peptide (Htt120Q) by GMR-promoter
induced degeneration of photoreceptor cells (Figure 1A, 1B). Co-
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expression of mouse Ku70 by GMR-GAL4/UAS-Ku70 remark-
ably recovered eye thickness of the Htt120Q transgenic flies
(Figure 1C). Quantitative analysis of eye thickness at one day after
eclosion confirmed that eye thickness was improved in
Htt120Q;Ku70 flies (29.162.1 mm) in comparison to Htt120Q
transgenic flies (20.661.5 mm) (Figure 1D). The expression of
mouse Ku70 did not affect the expression level of mutant Htt in
the transgenic fly (Figure 1E).
We next tested the effect of Drosophila Ku70 homologue
(gDmKu70, a genome rescue construct of Drosophila Ku70) on
the mutant Htt-induced eye degeneration to reconfirm the
rescuing effect (Figure 2). In this case, we used Htt103Q exon1
peptide (Htt103Q) because slippage-based expansion of polyQ
repeats occurred during plasmid construction and we could not
control the polyQ length. It might be a reason why eye
degeneration was slightly milder in Figure 2 than that in
Figure 1. However, beyond the minor difference, Ku70/DmKu70
across species was shown to reduce mutant Htt toxicity in the
Drosophila photoreceptor cells.
Ku70 elongates lifespan of Drosophila HD model
Since genetic interaction between Htt and Ku70/DmKu70 was
confirmed in eye degeneration with two independent transgenic
lines (Figure 1, 2), we next changed the driver in GAL4-UAS
system from GMR to motoneuron-specific OK6. Before this study,
we had made various types of neurodegenerative disease fly
models using multiple tissue-specific drivers, and had tested their
efficiency for screening modifier genes or chemicals (our
unpublished observation). Among them, several mutant genes
including Htt shorten the lifespan when they are expressed in
motor neurons by OK6-GAL4 driver (our unpublished observa-
tion). Thus, we decided to use the OK6-GAL4/lifespan model to
test the effect of Ku70 on the HD pathology.
At the beginning, we analyzed the life span of genetic
background flies used in this study. The life span of the Canton
S background flies, w(CS10), was shorter than the w1118
background flies in exactly similar culture conditions (Figure S1).
The lifespan of w(CS10) flies was not affected by Ku70 or OK6-
GAL4 transgene (Figure S2).
Figure 1. Ku70 reduces eye degeneration of mutant Htt in Drosophila models. (A-C) Axial sections of fly eyes from control Canton-S (A1
and A2), GMR-Htt120Q/+; GMR-Gal4/+ (Htt/+; B1 and B2) and GMR-Htt120Q/+; GMR-Gal4/UAS-mouse Ku70 (Htt/+;Ku70/+; C1 and C2) are shown at a
low power (Upper panel) or a high power (Lower panel) magnification. White arrows indicate the retina thickness of each transgenic fly. In triple
transgenic flies, co-expression of Ku70 partially repressed eye degeneration. Scale bar, 50 mm. (D) Quantitative analysis of the eye thickness of each
transgenic fly. The number of counted flies was indicated above each bar. Mean +/2 SE. *: p,0.01, Student’s t-test. (E) Western blot analysis of the
expression of mutant Htt (Htt120Q) and mouse Ku70 (Ku70) in fly eye. All flies tested were female. The genetic background was w(CS10) in this figure.
doi:10.1371/journal.pone.0027408.g001
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Then, we tested whether expression of human Htt103Q exon1
peptide affects the pupal eclosion rate: percentage of successful
eclosion from 100 pupae (Figure 3A) or the viability ratio: ratio
between balancer-negative adult flies and balancer-positive adult
flies generated from a single crossing (Figure 3B). The pupal
eclosion rate reflects the lethality at the pupal developmental stage,
while the viability ratio reflects the whole developmental lethality.
As described in the legend (Figure 3B), white bar in the graph
indicates the ratio of OK6/+;+/+ to CyO/+;+/+, black bar
indicates the ratio of OK6/+;Htt103Q/+ to CyO/+;Htt103Q/+,
and gray bar indicates the ratio of OK6/Ku70;Htt103Q/+ to
CyO/Ku70;Htt103Q/+. From the result of viability ratio
(Figure 3B), Htt103Q possessed a weak toxicity during develop-
ment and Ku70 was not effective for the developmental lethality.
Since pupal eclosion rate was not changed by Htt103Q expression
(Figure 3A), mutant Htt might be toxic for an early developmental
stage of larva.
We next analyzed the lifespan of OK6/+;+/+, OK6/+;
Htt103Q/+, and OK6/Ku70;Htt103Q/+. We found obvious
lifespan shortening by OK6-Gal4-mediated expression of
Htt103Q in motor neurons both in male and female flies
(Figure 3C, upper and lower panels). Co-expression of Ku70
clearly recovered the lifespan shortening by Htt103Q in male and
female flies, although the recovery did not reach to the level of
normal flies (Figure 3C). Co-expression of Ku70 in motor neurons
did not affect Htt103Q expression level in quantitative RT-PCR
(Figure S3) as in western blot for eye expression (Figure 1E). To
exclude the possibility of the transgene insertion effect, we tested
another independent transgenic line generated by injection of the
UAS-Ku70 vector to another egg. As expected, Ku70 rescued the
lifespan shortening by OK6-Gal4-mediated expression of
Htt103Q in motor neurons (Figure S4).
Ku70 reduction affects the lifespan of HD model fly
We tested the effect of Ku70 null mutation on the lifespan of
HD model flies. Heterozygous null mutation of Drosophila Ku70
gene (DmKu70EX8) did not shorten the lifespan of genetic
background flies (Figure 4A). When it was crossed with the HD
model flies, the heterozygous Ku70 null mutation accelerated the
lifespan shortening by OK6-Gal4-mediated expression of
Htt103Q in female flies (Figure 4B). The effect was not large
although the difference between the flies was confirmed
statistically. The acceleration was not confirmed in male flies
(Figure 4B).
Therefore, we next tried to test the effect of homozygous null
mutation of DmKu70 on the lifespan of HD model flies.
However, it was impossible because the homozygous null
mutant flies were embryonic lethal. Instead, we tested the effect
of compound heterozygous null mutation of Ku70 by using
DmKu707B2. Unexpectedly, we observed that the effect of
transheterozygous mutation was smaller than that of single
DmKu70EX8 mutation. We tested all possibilities that might
Figure 2. Drosophila homologue of Ku70 (DmKu70) has a protective effect in vivo against the toxicity of mutant Htt. (A) Axial sections
of the Control Canton-S, GMR-Gal4/+;UAS-Htt103Q/+ and GMR-Gal4/+;gDmKu70/UAS-Htt103Q fly eyes are shown. The vacuolar degeneration was
severer than that in Figure 2. In triple transgenic flies generated by mating GMR-Gal4/UAS-Htt103Q flies with UAS-mouse Ku70 flies, Ku70 co-
expression partially recovered degeneration. Scale bar, 50 mm. (B) Quantitative analysis of the eye thickness of each transgenic fly. The numbers
above each bar indicate the number of counted flies. Mean +/2 SE. *: p,0.01, Student’s t-test. All flies tested were female. Number of flies used for
the experiments are indicated on the shoulder of each bar. The genetic background was w(CS10) in this figure.
doi:10.1371/journal.pone.0027408.g002
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cause such a result. Finally, we found that the lifespan of
background flies for DmKu707B2 was artificially elongated (data
not shown) and that the elongation led to the unexpected result
in the transheterozygous mutation. Consequently, we could not
test the effect by compound heterozygous null mutation of
DmKu70EX8/DmKu707B2.
Figure 3. Ku70 reduces in vivo toxicity of mutant Htt in Drosophila models. (A) Eclosion rate is not reduced by motor neuron-specific
expression of human mutant Htt103Q with OK6-Gal4 driver. Pupae eclosed and became adult flies at a similar percentage in all genotypes (OK6/+;
+/+ for control, OK6/+; Htt 103Q/+ for disease model and OK6/Ku70; Htt103Q/+ for recovered flies). x2 statistics was used to test the difference
among groups. NS: not significant. (B) Viability is not reduced by motor neuron-specific expression of human mutant Htt103Q with OK6-Gal4 driver
(black bar). Viability here means the ratio between balancer-negative flies and balancer-positive flies generated from a single crossing. White bar
indicates the ratio between OK6/+;+/+ and CyO/+;+/+, black bar indicates the ratio between OK6/+;Htt103Q/+ and CyO/+;Htt103Q/+, and gray bar
indicates the ratio between OK6/Ku70;Htt103Q/+ and CyO/Ku70;Htt103Q/+. x2 statistics was used to test the difference among groups. NS: not
significant. (C) Lifespan shortening by OK6-Gal4-driven motor neuron-specific expression of human mutant Htt103Q was rescued by co-expression of
Ku70 by the same driver. Survival curves of males (upper panels) and females (lower panels) of control fly (OK6/+), disease model fly (OK6/+; Htt
103Q/+) and rescue fly (OK6/Ku70; Htt 103Q/+) were shown. Number of flies used for the experiments are 60 for OK6/+males, 59 for OK6/+; Htt 103Q/
+ males, 57 for OK6/Ku70; Htt 103Q/+ males, 100 for OK6/+ females, 60 for OK6/+; Htt 103Q/+ females and 57 for OK6/Ku70; Htt 103Q/+ females. The
genetic background was w(CS10) in this figure. The average lifespan and SD are shown. *p,0.05, **p,0.01, Wilcoxon’s test with Bonferroni’s
correction.
doi:10.1371/journal.pone.0027408.g003
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Ku70 reduction accelerates locomotion disability of HD
model fly
To address the effect of Ku70 reduction on HD phenotype, we
changed the way and tested whether Ku70 null mutation affects
the locomotion ability of Drosophila HD model (Figure 5) using
startle-induced negative geotactic response. We put a single fly in
to a test column, dropped it to the bottom by knocking the
column, and measured the time for fly to reach to 5 cm. By this
method, we evaluated locomotion ability of flies at 3, 7, and 14
days after eclosion. In this case, we used transheterozygous null
mutation of DmKu70EX8/DmKu707B2, because both background
did not affect locomotion ability. Although there was no
remarkable difference in the antigravity locomotion between
OK6/+ control flies and Htt103Q expressing flies, we found Ku70
mutation accelerates the age-dependent decline of locomotion
ability in Htt103Q expressing flies, specifically (Figure 5).
Interestingly, the acceleration was more prominent in female flies.
Furthermore, we used RNAi-mediated knock down (KD) of
Ku70 to confirm the relationship between Ku70 reduction and
mutant Htt-dependent phenotype. The result showed that Ku70-
KD induced locomotion disability of female HD model flies at 14
days but not of normal flies (Figure S5), supporting that
endogenous DmKu70 has a protective effect against the HD
pathology.
Discussion
In this study, we showed that Ku70 alleviates the HD
phenotypes in Drosophila models. We also showed that functional
deficiency of Ku70 accelerates the lifespan shortening and
locomotion disability of HD model flies. These results were
consistent with our previous observation that Ku70 remarkably
elongates the lifespan of R6/2 mice, the severest mouse model of
HD [27], and strongly support the significance of Ku70 as a
disease mediator/modifier gene and a therapeutic target.
Mutant Htt reduces DNA-PK activity and impairs the DNA
repair function of Ku70 in vitro [27]. In the double transgenic mice
generated from R6/2 and Ku70 transgenic mice, Ku70 reduces
DNA damage of striatal neurons [27]. These findings in our
Figure 4. Reduction of DmKu70 enhances in vivo toxicity of mutant Htt in Drosophila models. (A) Lifespan is not shortened by null
mutation of endogenous DmKu70 in driver (OK6-Gal4/+) control background. The survival curve of heterozygous DmKu70 null mutant (filled square:
OK6-Gal4/+; DmKu70EX8) was similar to that of DmKu70 wt (open diamond:OK6-Gal4/+; DmKu70+/+). (B) Lifespan is shortened by null mutation of
endogenous DmKu70 in female Htt model background (OK6-Gal4/+; UAS-Htt103Q/+). The survival of heterozygous DmKu70 null mutant (black
square: OK6-Gal4/+; UAS-Htt103Q/+; DmKu70EX8/+) was shorter than wt (open diamond: OK6-Gal4/+; UAS-Htt103Q/+; DmKu70+/+). Number of flies
used for the experiments are 61 for OK6/+ females, 80 for OK6-Gal4/+; DmKu70EX8/+ females, 58 for OK6-Gal4/+; UAS-Htt103Q/+ females, 68 for OK6-
Gal4/+; UAS-Htt103Q/+; DmKu70EX8/+ females, 42 for OK6/+ males, 75 for OK6-Gal4/+; DmKu70EX8/+ males, 61 for OK6-Gal4/+; UAS-Htt103Q/+ males
and 53 for OK6-Gal4/+; UAS-Htt103Q/+; DmKu70EX8/+ males. The genetic background for female flies was w1118 derived from Bloomington Drosophila
Stock Center. For male flies, the 2nd chromosome was w(CS10) and the 3rd chromosome was w1118 and the X chromosome was the mixture of
w(CS10) and w1118. The average lifespan and SD are shown. **p,0.01, Wilcoxon’s test.
doi:10.1371/journal.pone.0027408.g004
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previous study provide the idea that the functional defect of Ku70
underlies the HD pathology. However, it is also possible to
speculate that Ku70 blocks mutant Htt to prevent interaction
between mutant Htt and other target molecules and/or to inhibit
aggregation of mutant Htt. The two hypotheses are inseparable
and just like two sides of a coin. If we focus DNA repair, the two
stories are identical. If we consider certain pathology other than
DNA repair, the blocking effect might be more important.
With Drosophila, we could not directly evaluate DSBs in a few
motor neurons. It is because there is no fly orthologue of
mammalian H2AX, a direct indicator of DSB, and there is no
alternative method to detect DSB in neurons of Drosophila.
However, results in this study are basically consistent with our
previous observation that impairment of DSB repair is a critical
component in the HD pathology [26,27] and with previous reports
showing DNA damage signal activation in HD cell models
[26,34].
The concept of the linkage between DNA damage repair and
neurodegeneration is further supported by multiple autosomal
recessive cerebellar atrophies, in which mutations of DNA repair
Figure 5. Drosophila Ku70 mutation accelerates locomotion disability of mutant Htt transgenic flies. Startle-induced negative geotactic
response (time to reach to 5 cm high) was investigated. Control, heterozygous DmKu70 mutants, transheterozygous mutants, and their Htt103Q
expressing flies were tested at 3, 7 and 14 days after eclosion. Htt103Q expressers and non-expressers were compared separately. Significant
difference was observed between the HD background and its compound heterozygous mutant both in male and female flies. The numbers of
individual fly used for the analysis (N) are indicated above each bar. Experiments were performed three times with each fly, thus the actual ‘‘ n ’’ for
statistical analysis was three times of the fly number (N). We employed ANOVA and posthoc Dunnett’s test to compare them. *: p,0.05.
doi:10.1371/journal.pone.0027408.g005
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genes such as AOA1/EAOH [35], AOA2 [36], and SCAN1
[37,38] cause neuronal dysfunction and cell death. Therefore,
impairment of DNA damage repair could be considered as a
common pathological component across categories of neurode-
generative disorder.
In conclusion, our results further support that Ku70 is a critical
regulatory factor of Htt toxicity and a candidate for therapeutic
target of HD. This study has provided us a rationale to proceed to
the next step for translational approaches with Ku70 such as using
viral vectors expressing Ku70 or low molecular weight chemicals
against DSB in HD.
Materials and Methods
Western blot analysis
Western blot analysis was performed as described previously
[26]. Briefly, 50 female fly heads were dissolved in 100 ml of
62.5 mM Tris/HCl, pH 6.8, 2% (w/v) SDS, 2.5% (v/v) 2-
mercaptoethanol, 5% (v/v) glycerin, and 0.0025% (w/v) bromo-
phenol blue. Samples were separated by SDS-PAGE, transferred
onto Immobilon-P Transfer Membrane (Millipore) through a
semidry method, blocked by 5% milk in TBS with Tween 20
(TBST) (10 mM Tris/Cl, pH 8.0, 150 mM NaCl, 0.05% Tween
20). The filters were incubated with each primary antibody for
overnight at 4uC. Primary antibodies used were; mouse anti-
polyglutamine (1:2000, 1C2, Milipore), mouse anti-Ku70 (1:500,
N3H10, Kamiya Biomedical, Seattle) and mouse anti-actin
(1:2000, C4, Chemicon). The filters were then incubated with
horseradish peroxidase (HRP)-conjugated second antibody at a
1:3000 dilution for 1 h at room temperature in 5% milk/TBST
and visualized by Enhanced Chemiluminescence western blot
detection system (Amersham Biosciences, GE Health Care
Biosciences, Hong Kong).
Fly stocks and rearing conditions
Canton S, w(CS10) and w1118 (Bloomington Drosophila Stock
Center) were genetic backgrounds used for this study. All flies were
raised and maintained on a corn-meal medium at 25uC and
60% humidity in a 12:12 hr light-dark cycle. GMR-Gal4 is
P{longGMR-GAL4}3 and GMR-Huntingtin120Q line [40] were
obtained from Bloomington Drosophila stock center. UAS-mouse
Ku70 transgenic flies possessing a 1.8 kb full length cDNA of
AK143570 RIKEN clone were generated from a w(CS10) parental
strain. Ku70EX8 and Ku707B2 are deletion mutants of the Drosophila
Ku70 gene reported previously [39]. Genomic DmKu70 transgenic
fly (gDmKu70) was also reported previously [33]. UAS-Htt103Q fly
was made by P-element-mediated germline transformation.
pUAS-Htt103Q plasmid was constructed by subcloning human
HD exon1 cDNA digested from pTL1HA3-HD90Q with EcoRI
and NotI, into pUAST vector. pTL1HA3-HD90Q was made by
replacing the insert of pTL1HA3-HD51Q (pTL1-CAG51) [41]. w;
+/+; UAS-Htt103Q or w; gDmKu70; UAS-Htt103Q virgin females
were crossed with an eye specific driver GMR-Gal4 transgenic
males, and flies w; GMR-Gal4/+; UAS-Htt103Q/+ (disease model)
and w; GMR-Gal4/gDmKu70; UAS-Htt103Q/+ (recovery flies) were
generated.
To generate Ku70 RNAi fly, KK110409, in which an RNAi
construct has been inserted into 2nd chromosome, was purchased
from of Vienna Drosophila RNAi Center (VDRC). The virgin
female flies, w/w; RNAi/RNAi; +/+ were crossed with w/Y; +/
+; TM3 Ser/sb1 whose genetic background is w(CS10). The
resultant F1 virgin females, w/w; RNAi/+; TM3 Ser/+, were
crossed with w/Y; CyO/sp; Htt 103Q/Htt 103Q males (w(CS10)
background). The F2 flies, w/Y; CyO/RNAi; TM3 Ser/Htt 103Q
and w/Y; CyO/+; TM3 Ser/Htt 103Q can be distinguished by
their eye colors. Each males were crossed with OK6-Gal4
(w(CS10) background) virgin females. The final flies were w/w (or
Y); OK6/RNAi; Htt 103Q/+ and w/w (or Y); OK6/+; Htt
103Q/+.
We thank Dr. Dena Johnson-Schlitz and Dr. William Engels
(University of Wisconsin) for gDmKu70 transgenic and Ku70EX8
and Ku707B2 mutant flies, and Mrs. Tayoko Tajima for her
excellent technical support.
Fly lifespan and viability
The fly lifespan was analyzed as described [42]. The strains used
for the analysis were backcrossed more than three times to possess
the same genetic background. In a vial, 1 to 20 flies were reared
carefully to keep a good condition. Viability (the ratio between
balancer-negative adult flies and balancer-positive adult flies
generated from a single crossing) was calculated by counting the
number of eclosed adult flies of each genotype using balancer
phenotype. The lifespan of Canton S and w1118 was different as
shown in Figure S1, while the lifespan of a genetic background was
not affected by crossing Ku70 or OK6-GAL4 transgenic fly
(Figure S4). x2 statistics was used to test the difference of viability
among groups.
Fly eclosion rate
One hundred larvae at 3rd instar climbing on the wall were
collected carefully into a food vial. All the larvae pupate in a few
hours after collection. We counted the number of eclosed adult fly
until 1 week. The eclosion rate of control flies was almost similar
among various genotypes (data not shown). x2 statistics was used to
test the difference of eclosion among groups.
Fly eye morphology
Proboscis were removed from heads of adult female flies and
fixed in carnoy’s solution (ethanol: chloroform: acetate = 6:3(1) for
5(hours at 4(C, then dehydrated in serial dilutions of ethanol and
embedded in paraffin (pathoprep546, m.p. 54(56(C, Wako). Six((m
sections were stained with hemotoxylin-eosin (Merk) after re-
hydration. The sections were observed with a microscope and
analyzed using computer software, Metamorph (Molecular
Devices, Toronto, Canada).
Startle-induced negative geotactic response
A single fly was transferred in to a test column (150 mm in
length and 25 mm in diameter) lined with nylon mesh. We tapped
the column to drop the fly and recorded time for the fly to reach
5 cm from the bottom by a time watch. When a fly did not reach
5 cm within 10 sec, the time was recorded as 10 sec. The test was
repeated 3 times for each fly.
Quantitative PCR
Human Htt mRNA levels in transgenic flies were assessed by
quantitative real-time PCR (qPCR). Ten flies were collected from
each line, and total RNA was isolated from their whole bodies
using RNAeasy mini (Invitrogen). To eliminate genomic DNA
contamination, each sample was treated with DNase I (Promega,
Madison, WI) on column. First-strand cDNA was synthesized
from 200 ng of total RNA using Superscript II VILO (Invitrogen).
For qPCR, SYBER Green assays were performed using the
THUNDERBIRD (TOYOBO). The primers for Htt were Htt-
Forward, 59-ATGGCGACCCTGGAAAAGCT-39 and Htt-Re-
verse, 59-CGGTGGCGGCTGTTGCTG-39. Actin5C used as the
internal control was quantified with Actin5C-Forward, 59-
Genetic Interaction of Ku70 and Htt in Fly Models
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CCGAGCGCGGTTACTCTTT-39and Actin5C-Reverse, 59-
CAACATAGCACAGCTTCTCCTTGAT-39. The reactions
were analyzed by Applied Biosystems (Foster City, CA) Prism
7500.
Supporting Information
Figure S1 Different lifespans between Canton S and
w1118 genetic background flies. The lifespan was different
among Canton S homozygous, w1118 homozygous, and compound
heterozygous background flies.
(TIF)
Figure S2 The lifespan of the Canton S background flies
was not affected by OK6 or Ku70 transgene. (A) Lifespan
was not different between genetic controls and Ku70 overexpres-
sion fly. OK6/+ (w/Y; OK6-Gal4/+; +/+), Ku70/+; Htt 103Q/+
(w/Y; UAS-mKu70/+; UAS-Htt 103Q/+) and OK6/Ku70 (w/Y;
OK6-Gal4/UAS-mKu70; +/+). All flies tested were male. (B)
Eclosion rate was not different between genetic controls and Ku70
overexpression fly. The genotypes were, Canton-S (wild type),
OK6 (w; OK6-Gal4/+; +/+), Ku70-Htt 103Q (w; UAS-mKu70/
+; UAS-Htt 103Q/+), OK6-Ku70 (w; OK6-Gal4/UAS-mKu70;
+/+), OK6-Htt 103Q (w; OK6-Gal4/+; UAS-Htt 103Q/+) and
OK6-Htt 103Q-Ku70 (w; OK6-Gal4/UAS-mKu70; UAS-Htt
103Q/+).
(TIF)
Figure S3 Htt103Q expression was not affected by UAS-
Ku70 transgene. To exclude deprivation of GAL4 transcription
factor from UAS-Htt103Q by UAS-Ku70 underlies amelioration
of the phenotype, we performed RT-PCR to test expression level
of Htt103Q in different transgenic flies. The expression level of
Htt103Q was not changed by UAS-Ku70 transgene (n= 3,
Student’s t-test). Although recovery was larger in male flies
(Figure 3C), Htt was higher in male than female of Ku70
expressing flies.
(TIF)
Figure S4 Ku70 elongates the lifespan of an indepen-
dent line of Htt103Q-expressing flies. To exclude the
insertion effect of the Ku70 transgene, we tested another
transgenic line generated by independent injection of the UAS-
Ku70 vector. Consistently with the result in Figure 3C, we
observed that Ku70 rescued the lifespan shortening by Htt103Q.
(TIF)
Figure S5 Knock down of Drosophila Ku70 accelerates
locomotion disability of mutant Htt transgenic flies.
Startle-induced negative geotactic response was used to assess
locomotion ability of flies, and time to reach to 5 cm high was
counted. To test the effect of DmKu70 knock down on mutant Htt
expressing flies, we compared the time between Htt103Q
transgenic flies and DmKu70-KD/Htt103Q transgenic flies at 3,
7 and 14 days after eclosion. We found acceleration of locomotion
disability by DmKu70-KD in female flies. We employed ANOVA
and posthoc Dunnett’s test to compare them. *p,0.05.
(TIF)
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